K.J. Lillywhite

Complementary deoxyribonucleic acid cloning and expression of a human liver uridine diphosphate-glucuronosyltransferase glucuronidating carboxylic acid-containing drugs.

Chunjing Jin, John O. Miners, K.J. Lillywhite et al. · Journal of Pharmacology and Experimental Therapeutics · 1993 · 229 citations

cDNA Cloning and Expression of Two New Members of the Human Liver UDP-Glucuronosyltransferase 2B Subfamily

C.J. Jin, John O. Miners, K.J. Lillywhite et al. · Biochemical and Biophysical Research Communications · 1993 · 114 citations

Protein Expression, Hepatology, Biochemistry +12

Preclinical prediction of factors influencing the elimination of 5,6-dimethylxanthenone-4-acetic acid, a new anticancer drug.

John O. Miners, Luísa M.P. Valente, K.J. Lillywhite et al. · PubMed · 1997 · 63 citations

Chemoprevention Strategy, New Anticancer Drug, 5,6-Dimethylxanthenone-4-acetic Acid +21

Lidocaine disposition—Sex differences and effects of cimetidine

Lindon Wing, John O. Miners, D. J. Birkett et al. · Clinical Pharmacology & Therapeutics · 1984 · 61 citations

Kinetic and inhibitor studies of 4-methylumbelliferone and 1-naphthol glucuronidation in human liver microsomes

John O. Miners, K.J. Lillywhite, A.P. Matthews et al. · Biochemical Pharmacology · 1988 · 56 citations

Hepatology, Biochemistry, 1-Naphthol Glucuronidation +11